Investment
Features
FeesSafety
Academy
More
Pluang+

Avalanche hosts 350+ tokenized U.S. equities, including stocks and ETFs, boosting accessible blockchain investing.

Protocol Fundamentals
28 Sep 2026
Tokenpost
View Source
Bullish
Avalanche hosts 350+ tokenized U.S. equities, including stocks and ETFs, boosting accessible blockchain investing.

Avalanche's blockchain platform now supports over 350 tokenized U.S. equities through Dinari, including stocks, ETFs, and real estate trusts, all backed 1:1 by actual securities held in regulated custody. Securitize also launched its tokenized common stock, SECZ, on Avalanche and Solana, representing real NYSE-traded shares. This development aims to create a more accessible and programmable capital market while maintaining investor protections. With over $2 billion in tokenized securities linked to Avalanche, this marks a significant step in integrating traditional equities with blockchain technology, potentially broadening investment access globally.

Avalanche's expansion into tokenized U.S. equities provides context for cryptocurrency market activity on Pluang. For readers following digital assets, here is Pluang's market snapshot as of Sep 29, 2026 02:51 WIB: out of 50 major cryptocurrencies, 10 rose and 39 fell. Notable movers include FIL (Filecoin) at Rp18.747 with a 1-day change of -8.50%, BCH (Bitcoin Cash) at Rp5.517.177 down 8.28%, and ATOM (Cosmos) at Rp31.045 down 8.13%.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App